Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2018
|
| In: |
The lancet
Year: 2018, Volume: 17, Issue: 8, Pages: 681-688 |
| ISSN: | 1474-4465 |
| DOI: | 10.1016/S1474-4422(18)30176-5 |
| Online Access: | Resolving-System, Volltext: https://doi.org/10.1016/S1474-4422(18)30176-5 |
| Author Notes: | Albert C. Ludolph, Joachim Schuster, Johannes Dorst, Luc Dupuis, Jens Dreyhaupt, Jochen H. Weishaupt, Jan Kassubek, Ulrike Weiland, Susanne Petri, Thomas Meyer, Julian Grosskreutz, Berthold Schrank, Matthias Boentert, Alexander Emmer, Andreas Hermann, Daniel Zeller, Johannes Prudlo, Andrea S. Winkler, Torsten Grehl, Michael T. Heneka, Siw Wollebæk Johannesen, Bettina Göricke |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 1474-4465 |
| DOI: | 10.1016/S1474-4422(18)30176-5 |